RECOVER Study with St. Luke’s Continues
Data collected through the RECOVER study showed that by 14 days after the second dose of the Pfizer and Moderna vaccines, they are 90% protective against symptomatic and asymptomatic infection.
DULUTH, Minn. – The results are in for a national COVID study St. Luke’s hospital was involved in. Data collected through the RECOVER study showed that by 14 days after the second dose of the Pfizer and Moderna vaccines, they are 90% protective against symptomatic and asymptomatic infection. Previous studies showed that the vaccine was effective against symptomatic infection but…